调强放疗治疗鼻咽癌临床效果及并发症
2020-12-23周运生
周运生



[摘要] 目的 分析调强放疗治疗鼻咽癌临床效果及并发症。方法 随机选择2016年5月—2019年5月该院收治鼻咽癌患者100例,按随机数表分为两组,对照组50例采用常规放疗治疗,研究组50例使用调强放疗治疗,分析两组效果与并发症情况。结果 研究组临床总有效94.00%比对照组78.00%高,差异有统计学意义(χ2=5.316, P<0.05);研究组患者远期并发症发生率为12.00%,明显比对照组30.00%低,差异有统计学意义(χ2=4.882,P<0.05);研究组患者1年生存率94.00%、2年生存率88.00%明显高于对照组,比较差异有统计学意义(χ2=4.332、4.000,P<0.05)。结论 鼻咽癌患者采用调强放疗治疗,能提升患者放疗效果,改善其预后,还能减少并发症发生,安全性高。
[关键词] 调强放疗;常规放疗;鼻咽癌;临床效果;并发症
[中图分类号] R739 [文献标识码] A [文章编号] 1674-0742(2020)06(b)-0076-03
[Abstract] Objective To analyze the clinical effect and complications of intensity-modulated radiotherapy for nasopharyngeal carcinoma. Methods From May 2016 to May 2019, 100 patients with nasopharyngeal carcinoma were randomly selected in this hospital, and they were divided into two groups according to the random number table. The effects and complications of the two groups were analyzed. Results The total clinical effectiveness of the study group was 94.00% higher than that of the control group, 78.00%, the difference was statistically significant(χ2=5.316, P<0.05); the incidence of long-term complications in the study group was 12.00%, which was significantly lower than the control group 30.00%,the difference was statistically significant(χ2=4.882,P<0.05); The 1-year survival rate of patients in the study group was 94.00%, and the 2-year survival rate was 88.00%, which was significantly higher than that of the control group. The difference was statistically significant (χ2= 4.332, 4.000, P<0.05).Conclusion The use of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma can improve the patient's radiotherapy effect, improve its prognosis, and reduce the occurrence of complications. It has high safety.
[Key words] Intensity-modulated radiotherapy; Conventional radiotherapy; Nasopharyngeal carcinoma; Clinical effect; Complications
鼻咽癌在臨床耳鼻咽喉科中是一种较为常见恶性肿瘤疾病,其发病率为耳鼻喉恶性肿瘤首位[1]。鼻咽癌发病因素相对复杂,临床多认为与环境因素、遗传因素、病毒感染等因素密切相关,由于鼻咽癌患者的病情比较隐匿,临床易出现误诊或漏诊现象,且一旦确诊患者病情多发展为晚期,进而导致其错过了最佳时机[2]。对鼻咽癌疾病患者,临床主要采用放射治疗、手术切除、辅助化疗等方案,相关研究发现,对鼻咽癌患者采用常规放疗,能有效延缓疾病,但并发症比较多,效果不甚理想。近年来,调强放疗开始被应用于鼻咽癌疾病患者的临床治疗中,为进一步明确其临床疗效,该研究对该院2016年5月—2019年5月收治鼻咽癌100例患者资料分析,现报道如下。
1 资料与方法
1.1 一般资料
该研究经医学伦理会批准,随机选取在该院诊治鼻咽癌100例患者资料,排除标准:严重的肝肾疾病者,心理、精神者;按随机数表分两组,对照组(50例),女性23例,男性27例;年龄26~73岁,平均年龄(51.34±1.95)岁;原发癌16例,鼻咽癌并皮肌炎18例,隐性鼻咽癌16例。……
